DAA2266 |
Thioredoxin interacting protein increases with age |
Molecular |
temporal lobe |
Human |
TXNIP |
146.6% Increase Gene Expression Level |
|
DAA2267 |
Thioredoxin interacting protein increases with age |
Molecular |
temporal lobe |
Human |
TXNIP |
130.7% Increase Gene Expression Level |
|
DAA2205 |
toll-like receptor 2 increases with age |
Molecular |
temporal lobe |
Human |
TLR2 |
185.1% Increase Gene Expression Level |
|
DAA1100 |
Schlafen Family Member 11 |
Molecular |
temporal lobe |
Human |
SLFN11 |
Increase DNA Methylation |
|
DAA2206 |
S100 calcium binding protein A8 increases with age |
Molecular |
temporal lobe |
Human |
S100A8 |
530.6% Increase Gene Expression Level |
|
DAA1088 |
Rhomboid Domain Containing 1 |
Molecular |
temporal lobe |
Human |
RHBDD1 |
Increase DNA Methylation |
|
DAA1096 |
Prostaglandin E Receptor 3 (subtype EP3) |
Molecular |
temporal lobe |
Human |
PTGER3 |
Increase DNA Methylation |
|
DAA1080 |
Pipecolic Acid Oxidase |
Molecular |
temporal lobe |
Human |
PIPOX |
Increase DNA Methylation |
|
DAA2353 |
Pannexin 2 decreases with age |
Molecular |
temporal lobe |
Human |
PANX2 |
16.5% Decrease Gene Expression Level |
|
DAA2268 |
pannexin 1 decreases with age |
Molecular |
temporal lobe |
Human |
PANX1 |
41.6% Decrease Gene Expression Level |
|
DAA1104 |
Myogenic Differentiation 1 |
Molecular |
temporal lobe |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA2354 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
temporal lobe |
Human |
HLA-DRA |
150.4% Increase Gene Expression Level |
|
DAA2311 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
temporal lobe |
Human |
HLA-DRA |
146.7% Increase Gene Expression Level |
|
DAA2310 |
major histocompatibility complex, class II, DM alpha increases with age |
Molecular |
temporal lobe |
Human |
HLA-DMA |
110.6% Increase Gene Expression Level |
|
DAA1116 |
Growth Arrest-specific 2 Like 3 |
Molecular |
temporal lobe |
Human |
GAS2L3 |
Increase DNA Methylation |
|
DAA2271 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
Molecular |
temporal lobe |
Human |
FCGR2A |
124.0% Increase Gene Expression Level |
|
DAA2139 |
Fc fragment of IgG, high affinity Ib, receptor (CD64) increases with age |
Molecular |
temporal lobe |
Human |
FCGR1B |
166.0% Increase Gene Expression Level |
|
DAA2138 |
Fc fragment of IgG, high affinity Ia, receptor (CD64) increases with age |
Molecular |
temporal lobe |
Human |
FCGR1A |
151.0% Increase Gene Expression Level |
|
DAA2269 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
Molecular |
temporal lobe |
Human |
FCER1G |
144.2% Increase Gene Expression Level |
|
DAA2270 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
Molecular |
temporal lobe |
Human |
FCER1G |
98.1% Increase Gene Expression Level |
|
DAA1084 |
Dipeptidyl-peptidase 8 |
Molecular |
temporal lobe |
Human |
DPP8 |
Increase DNA Methylation |
|
DAA1112 |
Dickkopf-like 1 |
Molecular |
temporal lobe |
Human |
DKKL1 |
Increase DNA Methylation |
|
DAA2295 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
temporal lobe |
Human |
CX3CL1 |
46.7% Decrease Gene Expression Level |
|
DAA2168 |
Clusterin increases with age |
Molecular |
temporal lobe |
Human |
CLU |
25.9% Increase Gene Expression Level |
|
DAA2204 |
CD14 molecule increases with age |
Molecular |
temporal lobe |
Human |
CD14 |
154.3% Increase Gene Expression Level |
|